GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Samjin Pharmaceutical Co Ltd (XKRX:005500) » Definitions » Long-Term Debt

Samjin Pharmaceutical Co (XKRX:005500) Long-Term Debt : ₩2,083 Mil (As of Mar. 2024)


View and export this data going back to 1988. Start your Free Trial

What is Samjin Pharmaceutical Co Long-Term Debt?

Samjin Pharmaceutical Co's Long-Term Debt for the quarter that ended in Mar. 2024 was ₩2,083 Mil.

Samjin Pharmaceutical Co's quarterly Long-Term Debt declined from Sep. 2023 (₩6,250 Mil) to Dec. 2023 (₩4,167 Mil) and declined from Dec. 2023 (₩4,167 Mil) to Mar. 2024 (₩2,083 Mil).

Samjin Pharmaceutical Co's annual Long-Term Debt increased from Dec. 2021 (₩39,833 Mil) to Dec. 2022 (₩42,500 Mil) but then declined from Dec. 2022 (₩42,500 Mil) to Dec. 2023 (₩4,167 Mil).


Samjin Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for Samjin Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samjin Pharmaceutical Co Long-Term Debt Chart

Samjin Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 6,740.00 39,833.20 42,499.92 4,166.64

Samjin Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40,416.60 8,333.28 6,249.96 4,166.64 2,083.32

Samjin Pharmaceutical Co  (XKRX:005500) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Samjin Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Samjin Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Samjin Pharmaceutical Co (XKRX:005500) Business Description

Traded in Other Exchanges
N/A
Address
121, Wausan-ro, Mapo-Ku, Seoul, KOR, 121-837
Samjin Pharmaceutical Co Ltd is a part of the healthcare sector in Korea. The company functions as a pharmaceutical product manufacturer addressing severe diseases such as osteoporosis, hepatitis, respiratory and gastrointestinal diseases. Its suite of products includes capsules, syringes, injection medicines, and solvents.

Samjin Pharmaceutical Co (XKRX:005500) Headlines

No Headlines